Effect of 17-β estradiol on the expression of receptor activator of nuclear factor κB ligand and osteoprotegerin of human periodontal ligament cells during their osteogenic differentiation

Xiao-lin TANG,Huan-xin MENG,Li ZHANG,Jian-xia HOU,Jie HAN
DOI: https://doi.org/10.3321/j.issn:1671-167X.2007.01.014
2007-01-01
Abstract:Objective: To investigate the effect of 17-β estradiol (E_2)on the expression of receptor activator of nuclear factor κB ligand(RANKL) and osteoprotegerin(OPG) in human periodontal ligament cells( hPDLCs) during their osteogenic differentiation. Methods: hPDLCs of passage four were treated with 0.1% absolute ethyl alcohol (control), 10 -10 mol/L(physiological dose)or 10 -7 mol/L(high dose)E_2 in DMEM supplemented with 10% FBS, 10 mM β-glycerophosphate and 5 μg/ml ascorbic acid for 24 hours, 48 hours and 72 hours. Levels of RANKL and OPG mRNA were detected with real-time quantitative RT-PCR. Results: High dose E_2 induced a time-dependent decrease of RANKL mRNA and expression levels were 31.0%, 23.6% and 15.4% of the controls at 24 h, 48 h and 72 h respectively while expression levels with physiological dose E_2 were 28.4%, 87.3% and 22.6% of the controls respectively. On the other hand, E_2 increased OPG mRNA expression levels of hPDLCs which reached the maximum at 72 h with physiological dose E_2, 210.1% of the controls and with high dose E_2, 171.3% of the controls. Conclusion: These results suggest that estrogen may exert anti-resorptive effects on alveolar bone by regulating the expression of RANKL and OPG in hPDLCs during their osteogenic differentiation.
What problem does this paper attempt to address?